早期前交叉韧带重建优于初始非重建治疗后晚期交叉手术:瑞典国家膝关节韧带登记研究
基于瑞典国家膝关节韧带登记数据的队列研究(证据等级2),比较早期前交叉韧带重建、非重建治疗及初始非重建后晚期交叉手术三组患者的KOOS评分与PASS达标率。交叉组KOOS4在基线及1、2、5、10年随访均低于早期重建组,PASS达标比例也更低;交叉组与非重建组在各随访点无差异。结论认为早期重建患者报告可接受膝关节功能和更优整体膝关节功能的比例更高。
要点
- 交叉组KOOS4在基线及1、2、5、10年随访均低于早期重建组,平均差异(95%CI)分别为-6.5(-8.0至-5.0)、-9.3(-10.9至-7.7)、-4.8(-6.3至-3.2)、-6.1(-8.8至-3.4)、-10.9(-16.3至-5.2)。
- 交叉组在基线及1、2、5、10年随访达到KOOS各亚量表PASS的比例均低于早期重建组。
- 交叉组与非重建组在KOOS4或PASS各随访点均无差异。
核心结论
- 早期前交叉韧带重建患者报告可接受膝关节功能和更优整体膝关节功能的比例高于初始非重建治疗后晚期交叉手术的患者。
研究设计与样本
- 队列研究,证据等级2,数据来自瑞典国家膝关节韧带登记,纳入交叉组1074例、非重建组484例、早期前交叉韧带重建组20352例。
主要发现
- 交叉组KOOS4低于早期重建组,基线平均差异-6.5(95%CI -8.0至-5.0),1年-9.3(-10.9至-7.7),2年-4.8(-6.3至-3.2),5年-6.1(-8.8至-3.4),10年-10.9(-16.3至-5.2)。
- 交叉组在基线及1、2、5、10年随访达到KOOS各亚量表PASS的比例低于早期重建组。
- 交叉组与非重建组在KOOS4或PASS各随访点均无差异。
关键数值与推荐
- KOOS4为4个KOOS亚量表的均值,在基线及1、2、5、10年随访进行横断面分析。
- PASS应用于基线至10年随访的所有KOOS亚量表。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although comparable clinical and functional outcomes have been reported after nonsurgical and surgical anterior cruciate ligament (ACL) treatment, few studies have investigated the effects of early versus late ACL reconstruction with initial rehabilitation. PURPOSE: To determine patient-reported knee function in patients who initially undergo nonreconstructive treatment after an ACL injury but who later choose to undergo ACL reconstruction as compared with (1) patients undergoing ACL reconstruction close to the index injury and (2) patients treated nonreconstructively at 1 to 10 years of follow-up. STUDY DESIGN: Cohort study; Level of evidence, 2. METHODS: Results from the Knee injury and Osteoarthritis Outcome Score (KOOS) were extracted from the Swedish National Knee Ligament Registry for patients treated with nonreconstruction, early ACL reconstruction, and initial nonreconstruction but subsequent ACL reconstruction (crossover group). The KOOS4 (a mean of 4 KOOS subscales) was analyzed cross-sectionally at baseline and at the 1-, 2-, 5-, and 10-year follow-ups. Additionally, the Patient Acceptable Symptom State (PASS) was applied to all KOOS subscales from baseline to the 10-year follow-up. RESULTS: A total of 1,074 crossover, 484 nonreconstruction, and 20,352 early ACL reconstruction cases were included. The crossover group reported lower KOOS4 values than the group undergoing early ACL reconstruction at baseline and at all follow-ups (mean difference [95% CI]): baseline, -6.5 (-8.0 to -5.0); 1 year, -9.3 (-10.9 to -7.7); 2 years, -4.8 (-6.3 to -3.2); 5 years, -6.1 (-8.8 to -3.4); and 10 years, -10.9 (-16.3 to -5.2). Additionally, a smaller proportion of the crossover cohort achieved a PASS on KOOS subscales at baseline and through the 1-, 2-, 5-, and 10-year follow-ups as compared with the early ACL reconstruction cohort. No differences were observed between crossover and nonreconstruction cases on either the KOOS4 or the PASS at any follow-up. CONCLUSION: A greater proportion of patients treated with early ACL reconstruction reported acceptable knee function and superior overall knee function as compared with patients who decided to cross over from nonreconstructive treatment to ACL reconstruction.
引用
- Bergerson E, Persson K, Svantesson E, et al. Superior Outcome of Early ACL Reconstruction versus Initial Non-reconstructive Treatment With Late Crossover to Surgery: A Study From the Swedish National Knee Ligament Registry. Am J Sports Med. 2022. PMID: 35107352. doi:10.1177/03635465211069995
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。